MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview

Medicinova

11/08/2025 21:21

MediciNova Inc MNOV.OQ MNOV.O is expected to  show no change in quarterly revenue when it reports  results on August 13 for the period ending June 30 2025

​LSEG's mean analyst estimate for MediciNova Inc is for a loss of 9 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for MediciNova Inc is $7.00, about 80.7% above its last closing price of $1.35

This summary was machine generated August 11 at 20:21 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)